Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotine and Smoking Cessation in Schizophrenia

NCT00307203 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00307203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotine and Smoking Cessation in Schizophrenia
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 4
Overall status
Completed
Start date
August 31, 1998
Completion date
February 29, 2004
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychotic disorders, schizophrenia, tobacco-use disorder